Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock
- PMID: 34582425
- DOI: 10.1097/CCM.0000000000005317
Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock
Abstract
Objectives: To determine the association of catecholamine dose, lactate concentration, and timing from shock onset at vasopressin initiation with in-hospital mortality.
Design: Retrospective, observational study using segmented and multivariable logistic regression to evaluate the associations of catecholamine dose, lactate concentration, and timing from shock onset at vasopressin initiation with in-hospital mortality.
Setting: Multiple hospitals within the Cleveland Clinic Health System.
Patients: Adult patients who met criteria for septic shock based on the U.S. Centers for Disease Control and Prevention Adult Sepsis Event definition.
Interventions: All patients received continuous infusion vasopressin as an adjunct to catecholamine vasopressors.
Measurements and main results: In total, 1,610 patients were included with a mean Acute Physiology and Chronic Health Evaluation III 109.0 ± 35.1 and Sequential Organ Failure Assessment 14.0 ± 3.5; 41% of patients survived the hospital admission. At the time of vasopressin initiation, patients had median (interquartile range) lactate concentration 3.9 mmol/L (2.3-7.2 mmol/L), norepinephrine-equivalent dose 25 µg/min (18-40 µg/min), and 5.3 hours (2.1-12.2 hr) elapsed since shock onset. The odds of in-hospital mortality increased 20.7% for every 10 µg/min increase in norepinephrine-equivalent dose up to 60 µg/min at the time of vasopressin initiation (adjusted odds ratio, 1.21 [95% CI, 1.09-1.34]), but no association was detected when the norepinephrine-equivalent dose exceeded 60 µg/min (adjusted odds ratio, 0.96 [95% CI, 0.84-1.10]). There was a significant interaction between timing of vasopressin initiation and lactate concentration (p = 0.02) for the association with in-hospital mortality. A linear association between increasing in-hospital mortality was detected for increasing lactate concentration at the time of vasopressin initiation, but no association was detected for time elapsed from shock onset.
Conclusions: Higher norepinephrine-equivalent dose at vasopressin initiation and higher lactate concentration at vasopressin initiation were each associated higher in-hospital mortality in patients with septic shock who received vasopressin.
Copyright © 2022 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Conflict of interest statement
Dr. Bauer reports that he is a consultant for Wolters Kluwer, and he received funding from Wolters Kluwer. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Comment in
-
Early Multimodal Vasopressors-Are We Ready for It?Crit Care Med. 2022 Apr 1;50(4):705-708. doi: 10.1097/CCM.0000000000005344. Crit Care Med. 2022. PMID: 35311781 No abstract available.
-
Potential Confounders in Study Concluding Higher Lactate at Vasopressin Initiation Is Associated With Higher Mortality in Septic Shock.Crit Care Med. 2022 Oct 1;50(10):e775-e776. doi: 10.1097/CCM.0000000000005615. Epub 2022 Sep 12. Crit Care Med. 2022. PMID: 36106977 No abstract available.
Similar articles
-
The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.Crit Care Med. 2017 Jun;45(6):940-948. doi: 10.1097/CCM.0000000000002323. Crit Care Med. 2017. PMID: 28333757 Clinical Trial.
-
Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study.Crit Care Explor. 2022 Feb 8;4(2):e0634. doi: 10.1097/CCE.0000000000000634. eCollection 2022 Feb. Crit Care Explor. 2022. PMID: 35156051 Free PMC article.
-
Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.BMC Infect Dis. 2023 Apr 3;23(1):199. doi: 10.1186/s12879-023-08147-6. BMC Infect Dis. 2023. PMID: 37013474 Free PMC article.
-
Optimizing Vasopressin Use and Initiation Timing in Septic Shock: A Narrative Review.Chest. 2023 Nov;164(5):1216-1227. doi: 10.1016/j.chest.2023.07.009. Epub 2023 Jul 20. Chest. 2023. PMID: 37479058 Free PMC article. Review.
-
Narrative Review of Controversies Involving Vasopressin Use in Septic Shock and Practical Considerations.Ann Pharmacother. 2020 Jul;54(7):706-714. doi: 10.1177/1060028020901521. Epub 2020 Jan 20. Ann Pharmacother. 2020. PMID: 31958982 Review.
Cited by
-
The Eight Unanswered and Answered Questions about the Use of Vasopressors in Septic Shock.J Clin Med. 2023 Jul 10;12(14):4589. doi: 10.3390/jcm12144589. J Clin Med. 2023. PMID: 37510705 Free PMC article. Review.
-
Effect of early adjunctive vasopressin initiation for septic shock patients: a target trial emulation.Crit Care. 2025 May 12;29(1):188. doi: 10.1186/s13054-025-05401-y. Crit Care. 2025. PMID: 40355911 Free PMC article.
-
Vasopressin use across shock states: international insights from an international ESICM-endorsed survey: the PRESS Survey.Crit Care. 2025 Jul 3;29(1):273. doi: 10.1186/s13054-025-05505-5. Crit Care. 2025. PMID: 40611266 Free PMC article.
-
Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise?Crit Care. 2025 Jul 29;29(1):333. doi: 10.1186/s13054-025-05540-2. Crit Care. 2025. PMID: 40731360 Free PMC article. Review.
-
Vasopressor Choice and Timing in Vasodilatory Shock.Crit Care. 2022 Mar 22;26(1):76. doi: 10.1186/s13054-022-03911-7. Crit Care. 2022. PMID: 35337346 Free PMC article. Review.
References
-
- Kadri SS, Rhee C, Strich JR, et al.: Estimating ten-year trends in septic shock incidence and mortality in United States academic medical centers using clinical data. Chest 2017; 151:278–285
-
- Vincent JL, Jones G, David S, et al.: Frequency and mortality of septic shock in Europe and North America: A systematic review and meta-analysis. Crit Care 2019; 23:196
-
- Buchman TG, Simpson SQ, Sciarretta KL, et al.: Sepsis among Medicare beneficiaries: 1. The burdens of sepsis, 2012-2018. Crit Care Med 2020; 48:276–288
-
- Rhodes A, Evans LE, Alhazzani W, et al.: Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43:304–377
-
- Gordon AC, Mason AJ, Thirunavukkarasu N, et al.; VANISH Investigators: Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial. JAMA 2016; 316:509–518
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous